Clinical Trials of Phase 1, 2 of Nanocovax Manufactured by Nanogen
Latest Information Update: 06 Dec 2022
At a glance
- Drugs COVID 2019 vaccine-Nanogen Biopharmaceutical Co (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Nanogen Biopharmaceutical Co
- 31 Dec 2020 New trial record